The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innov ...
Pharmaceutical Technology on MSN
Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.
Zacks Investment Research on MSN
Novavax grants license for use of Matrix-M adjuvant to Pfizer
Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...
Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost Your email has been sent Pfizer and Boltz have announced a collaboration aimed at expanding the use of advanced biomolecular AI ...
Pfizer's coronavirus-related sales have fallen sharply -- and they may decline even further next year. The company is developing some promising products, including a flu vaccine and a weight loss ...
For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results